Biotech · Private company
Tanabe Pharma America, Inc.
Track this companyFree. Adds Tanabe Pharma America, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials223 recruiting or active
Pipeline programs20From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline20
- AST-120Phase 3 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DersimelagonPhase 3 · Erythropoietic Protoporphyria (EPP)ClinicalTrials.gov · fetched Nov 12, 2026
- MCI-196Phase 3 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MT-7117Phase 3 · EPPClinicalTrials.gov · fetched Nov 12, 2026
- MT-7117 High DosePhase 3 · EPPClinicalTrials.gov · fetched Nov 12, 2026
- MT-7117 Low DosePhase 3 · EPPClinicalTrials.gov · fetched Nov 12, 2026
- MT-2990Phase 2 · Endometrial Related PainClinicalTrials.gov · fetched Nov 12, 2026
- MT-3921Phase 2 · Spinal Cord InjuryClinicalTrials.gov · fetched Nov 12, 2026
- MT-4561Phase 2 · Head and Neck Squamous Cell Carcinoma (HNSCC)ClinicalTrials.gov · fetched Nov 12, 2026
- MT-7117Phase 2 · Diffuse Cutaneous Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- MT-7117 high dosePhase 2 · Erythropoietic Protoporphyria (EPP)ClinicalTrials.gov · fetched Nov 12, 2026
- MT-7117 low dosePhase 2 · Erythropoietic Protoporphyria (EPP)ClinicalTrials.gov · fetched Nov 12, 2026
- MT-8554Phase 2 · Vasomotor Symptoms (VMS)ClinicalTrials.gov · fetched Nov 12, 2026
- MT-8554 10mgPhase 2 · Menopause Hot FlashesClinicalTrials.gov · fetched Nov 12, 2026
- MT-8554 1mgPhase 2 · Menopause Hot FlashesClinicalTrials.gov · fetched Nov 12, 2026
- MT-8554 5mgPhase 2 · Menopause Hot FlashesClinicalTrials.gov · fetched Nov 12, 2026
- moxifloxacinPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- MT-3921 Low dosePhase 1 · Spinal Cord InjuryClinicalTrials.gov · fetched Nov 12, 2026
- MT-7117Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- MT-7117Phase 1 · Mild and Moderate Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials22
- A Study of MT-4561 in Patients With Various Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Apr 18, 2025ClinicalTrials.gov NCT06943521 · fetched Nov 12, 2026
- INcreased Sun Exposure Without Pain In Research Participants With EPP or XLPPHASE3 · COMPLETED · started Dec 11, 2023ClinicalTrials.gov NCT06144840 · fetched Nov 12, 2026
- Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)COMPLETED · started Feb 21, 2022ClinicalTrials.gov NCT05276349 · fetched Nov 12, 2026
- Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy SubjectsPHASE1 · COMPLETED · started Jan 12, 2022ClinicalTrials.gov NCT05241535 · fetched Nov 12, 2026
- Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord InjuryPHASE2 · COMPLETED · started Aug 27, 2021ClinicalTrials.gov NCT04683848 · fetched Nov 12, 2026
- Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 10, 2021ClinicalTrials.gov NCT05005975 · fetched Nov 12, 2026
- Telespirometry in Amyotrophic Lateral Sclerosis (ALS)UNKNOWN · started Apr 28, 2021ClinicalTrials.gov NCT05106569 · fetched Nov 12, 2026
- Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy SubjectsPHASE1 · COMPLETED · started Mar 23, 2021ClinicalTrials.gov NCT04793295 · fetched Nov 12, 2026
- Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic SclerosisPHASE2 · COMPLETED · started Feb 5, 2021ClinicalTrials.gov NCT04440592 · fetched Nov 12, 2026
- Analysis of Human ALS Tissues and Registry of ALS PatientsRECRUITING · started Sep 1, 2020ClinicalTrials.gov NCT05067179 · fetched Nov 12, 2026
- Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked ProtoporphyriaPHASE3 · COMPLETED · started Jun 1, 2020ClinicalTrials.gov NCT04402489 · fetched Nov 12, 2026
- Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord InjuryPHASE1 · COMPLETED · started Apr 19, 2020ClinicalTrials.gov NCT04096950 · fetched Nov 12, 2026
- Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic FunctionPHASE1 · COMPLETED · started Aug 1, 2019ClinicalTrials.gov NCT04116476 · fetched Nov 12, 2026
- Safety and Efficacy Study of MT-2990 in Women With EndometriosisPHASE2 · COMPLETED · started Jan 15, 2019ClinicalTrials.gov NCT03840993 · fetched Nov 12, 2026
- Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic ProtoporphyriaPHASE2 · COMPLETED · started Jul 5, 2018ClinicalTrials.gov NCT03520036 · fetched Nov 12, 2026
- Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor SymptomsPHASE2 · COMPLETED · started Apr 18, 2018ClinicalTrials.gov NCT03541200 · fetched Nov 12, 2026
- MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal WomenPHASE2 · COMPLETED · started Oct 9, 2017ClinicalTrials.gov NCT03291067 · fetched Nov 12, 2026
- Tryptophan MRI in People With Schizophrenia and Healthy ControlsPHASE2_PHASE3 · COMPLETED · started Aug 14, 2014ClinicalTrials.gov NCT02067975 · fetched Nov 12, 2026
- Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaPHASE3 · COMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00772382 · fetched Nov 12, 2026
- A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With HyperphosphatemiaPHASE3 · COMPLETED · started Sep 1, 2007ClinicalTrials.gov NCT00506441 · fetched Nov 12, 2026
- A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)PHASE3 · COMPLETED · started Jul 1, 2007ClinicalTrials.gov NCT00500682 · fetched Nov 12, 2026
- A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)PHASE3 · COMPLETED · started Jul 1, 2007ClinicalTrials.gov NCT00501046 · fetched Nov 12, 2026